Researchers assessing 22 predictive models of cardiovascular disease risk find that none accurately predict its occurrence in a population of people with type 2 diabetes.
Individuals with type 1 diabetes continue to experience severe and level 2 hypoglycemia despite the use of continuous glucose monitoring systems, with the risk potentially influenced by personal beliefs, US research shows.
BMI has a strong positive linear association with type 2 diabetes risk that generally does not vary by global region or ethnicity, show results of a dose-response meta-analysis.
Mortality in people with diabetes is declining in most high-income countries, in many cases faster than in people without diabetes, researchers report.
Findings from the COVAC-DM study suggest that people with type 1 or type 2 diabetes have an antibody response to COVID-19 vaccination that is similar to healthy individuals, with no association between glycemic control and antibody levels.
Researchers find that the type of benefits people with type 1 diabetes gain from hybrid closed-loop insulin delivery differs according to their baseline glycemic control.
Real-world data from Canada show that increasing maternal glycemia is associated with rising rates of large for gestational age births, confirming the results of the landmark HAPO trial.
Early intensive glycemic control may reduce the long-term risk for foot ulcers in people with type 1 diabetes, suggest data from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
People with type 2 diabetes and chronic kidney disease have a high residual risk for cardiorenal events and high rates of treatment failure after initiation of SGLT2 inhibitors, real-world study findings indicate.
Semaglutide 2.4 mg produces substantially more weight loss than liraglutide 3.0 mg in people with overweight or obesity but without diabetes, say the STEP 8 investigators.
Structured monitoring of blood glucose improves its control regardless of the device used, although continuous glucose monitoring is better than self-monitored blood glucose for reducing hypoglycemia, shows a randomized trial.
The proportion of on-target interstitial glucose values falls during the week following initial COVID-19 vaccination in people with type 1 diabetes, study findings indicate.
Having first-degree relatives with type 2 diabetes may be associated with an increased risk for cardiovascular disease and microvascular complications among people with type 1 diabetes, particularly those diagnosed at a young age, study findings suggest.
Initiating metformin following hospitalization for heart failure may reduce the risk for death or further HHF in older people with comorbid diabetes, but only if they have a preserved ejection fraction, study findings indicate.
An update from an international study has shown that although glycemic control has improved with time among people with type 1 diabetes, it remains suboptimal and continues to vary substantially by country, age group, and data source.
Children with islet autoantibodies who spend more than 10% of their time with hyperglycemic glucose levels are highly likely to progress to clinical diabetes within the next year, show findings from the ASK study.
Findings from the ORACL trial suggest that closed-loop insulin delivery results in better glycemic control than sensor-augmented pump therapy among older adults with longstanding type 1 diabetes.